| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2002PNAS...9914428H |
| P356 | DOI | 10.1073/PNAS.222375399 |
| P8608 | Fatcat ID | release_luhvpbaox5fbpbextxm6ukmk3m |
| P932 | PMC publication ID | 137900 |
| P698 | PubMed publication ID | 12391297 |
| P5875 | ResearchGate publication ID | 11071599 |
| P50 | author | Ryouhei Tsutsumi | Q56015556 |
| Masanori Hatakeyama | Q90553202 | ||
| P2093 | author name string | Masahiro Asaka | |
| Takeshi Azuma | |||
| Akiko Fujita | |||
| Hideaki Higashi | |||
| Shiho Yamazaki | |||
| P2860 | cites work | Induction of host signal transduction pathways by Helicobacter pylori | Q34741347 |
| Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation | Q35015052 | ||
| cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors | Q37047617 | ||
| Analyses of the cag pathogenicity island of Helicobacter pylori | Q42677857 | ||
| Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. | Q42819835 | ||
| Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells | Q43808787 | ||
| Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. | Q44755796 | ||
| Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer | Q48019587 | ||
| Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries | Q57216315 | ||
| Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH | Q57216597 | ||
| Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States | Q57217616 | ||
| Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains | Q71673010 | ||
| Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach | Q72220074 | ||
| Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils | Q77391803 | ||
| Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype | Q77900398 | ||
| Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori | Q22122443 | ||
| Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1 | Q24305352 | ||
| Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor | Q24310840 | ||
| Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2 | Q24314461 | ||
| Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer | Q24562562 | ||
| Crystal structure of the tyrosine phosphatase SHP-2 | Q27748898 | ||
| Helicobacter pylori infection induces gastric cancer in mongolian gerbils | Q28280923 | ||
| Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori | Q28776428 | ||
| Helicobacter pylori infection and the development of gastric cancer | Q29615341 | ||
| c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs | Q30829845 | ||
| Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus | Q30981200 | ||
| SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities | Q31096727 | ||
| SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein | Q33292154 | ||
| Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection | Q33617838 | ||
| Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies | Q33670744 | ||
| Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases | Q33675894 | ||
| Differences in genotypes of Helicobacter pylori from different human populations | Q33994164 | ||
| Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells | Q34507295 | ||
| Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion | Q34507324 | ||
| Helicobacter pylori and atrophic gastritis: importance of the cagA status | Q34718764 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Helicobacter pylori | Q180556 |
| phosphorylation | Q242736 | ||
| Helicobacter pylori infectious disease | Q4497153 | ||
| P304 | page(s) | 14428-14433 | |
| P577 | publication date | 2002-10-21 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites | |
| P478 | volume | 99 |
| Q50739945 | A C-terminal translocation signal is necessary, but not sufficient for type IV secretion of the Helicobacter pylori CagA protein. |
| Q42732055 | A Tale of Two Toxins: Helicobacter Pylori CagA and VacA Modulate Host Pathways that Impact Disease |
| Q33515285 | A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. |
| Q39236598 | A mutagenesis method for the addition and deletion of highly repetitive DNA regions: the paradigm of EPIYA motifs in the cagA gene of Helicobacter pylori |
| Q36066072 | A new subtype of 3' region of cagA gene in Helicobacter pylori strains isolated from Zhejiang Province in China |
| Q34685469 | A novel inhibitory domain of Helicobacter pylori protein CagA reduces CagA effects on host cell biology. |
| Q52629636 | A potential association between Helicobacter pylori CagA EPIYA and multimerization motifs with cytokeratin 18 cleavage rate during early apoptosis. |
| Q28546771 | A specific A/T polymorphism in Western tyrosine phosphorylation B-motifs regulates Helicobacter pylori CagA epithelial cell interactions |
| Q33787697 | Adherence and invasion of mouse-adapted H pylori in different epithelial cell lines |
| Q33756876 | African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths |
| Q37156014 | Alanine-threonine polymorphism of Helicobacter pylori RpoB is correlated with differential induction of interleukin-8 in MKN45 cells |
| Q54267284 | Amino acid polymorphisms flanking the EPIYA-A motif of Helicobacter pylori CagA C-terminal region is associated with gastric cancer in east China: experience from a single center. |
| Q33637846 | Analysis of 3'-end variable region of the cagA gene in Helicobacter pylori isolated from Iranian population. |
| Q37421295 | Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey |
| Q37451639 | Analysis of clarithromycin resistance and CagA status in Helicobacter pylori by use of feces from children in Thailand |
| Q34173782 | Analysis of clinical isolates of Helicobacter pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance |
| Q57212340 | Analysis of the 3' variable region of the cagA gene of Helicobacter pylori isolated in Koreans |
| Q33531871 | Analysis of translocation of the CagA protein and induction of a scattering phenotype in AGS cells infected with Helicobacter pylori |
| Q33533972 | Application of PCR amplicon sequencing using a single primer pair in PCR amplification to assess variations in Helicobacter pylori CagA EPIYA tyrosine phosphorylation motifs |
| Q34322144 | Association between cagA and vacA genotypes and pathogenesis in a Helicobacter pylori infected population from South-eastern Sweden |
| Q30234657 | Association of CagA EPIYA-D or EPIYA-C phosphorylation sites with peptic ulcer and gastric cancer risks: A meta-analysis |
| Q50055723 | Associations Between CagA, VacA, and the Clinical Outcomes of Helicobacter Pylori Infections in Okinawa, Japan. |
| Q33480292 | Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese |
| Q35314130 | Attenuated CagA oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon |
| Q38050868 | Bacterial EPIYA effectors--where do they come from? What are they? Where are they going? |
| Q38624717 | Bacterial protein toxins in human cancers. |
| Q39599040 | CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. |
| Q36828545 | CagA EPIYA polymorphisms in Colombian Helicobacter pylori strains and their influence on disease-associated cellular responses. |
| Q37199861 | CagA Phosphorylation in Helicobacter pylori-Infected B Cells Is Mediated by the Nonreceptor Tyrosine Kinases of the Src and Abl Families |
| Q33909465 | CagA and VacA polymorphisms are associated with distinct pathological features in Helicobacter pylori-infected adults with peptic ulcer and non-peptic ulcer disease. |
| Q37302167 | CagA and VacA polymorphisms do not correlate with severity of histopathological lesions in Helicobacter pylori-infected Greek children |
| Q40095300 | CagA-independent disruption of adherence junction complexes involves E-cadherin shedding and implies multiple steps in Helicobacter pylori pathogenicity |
| Q42716561 | Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis |
| Q34604754 | Characterization of CagA variable region of Helicobacter pylori isolates from Chinese patients |
| Q35192162 | Characterization of Helicobacter pylori cagA and vacA genotypes among Alaskans and their correlation with clinical disease |
| Q90247381 | Characterization of a novel Helicobacter pylori East Asian-type CagA ELISA for detecting patients infected with various cagA genotypes |
| Q50083334 | Characterizing Helicobacter pylori cagA in Myanmar. |
| Q37427454 | Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review |
| Q37328454 | Coadaptation of Helicobacter pylori and humans: ancient history, modern implications |
| Q37943938 | Coevolution and adaptation of Helicobacter pylori and the case for 'functional molecular infection epidemiology'. |
| Q34576087 | Comparative genomic analysis of East Asian and non-Asian Helicobacter pylori strains identifies rapidly evolving genes. |
| Q35075817 | Complex cellular responses of Helicobacter pylori-colonized gastric adenocarcinoma cells |
| Q30365619 | Computational approaches for evaluating the effect of sequence variations and the intrinsically disordered C-terminal region of the Helicobacter pylori CagA protein on the interaction with tyrosine kinase Src. |
| Q44887884 | Conditional gene silencing utilizing the lac repressor reveals a role of SHP-2 in cagA-positive Helicobacter pylori pathogenicity |
| Q38709527 | Cot kinase plays a critical role in Helicobacter pylori-induced IL-8 expression. |
| Q41480432 | Creation and Initial Characterization of Isogenic Helicobacter pylori CagA EPIYA Variants Reveals Differential Activation of Host Cell Signaling Pathways |
| Q35045616 | Deletion of cagA gene of Helicobacter pylori by PCR products |
| Q35297763 | Diagnosis of Helicobacter pylori: what should be the gold standard? |
| Q37402997 | Differences in amino acid frequency in CagA and VacA sequences of Helicobacter pylori distinguish gastric cancer from gastric MALT lymphoma |
| Q38609595 | Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease |
| Q55177690 | Different Pathophysiology of Gastritis between East and West? An Asian Perspective. |
| Q37444940 | Differential expression of a virulence factor in pathogenic and non-pathogenic mycobacteria. |
| Q40938007 | Distinct diversity of the cag pathogenicity island among Helicobacter pylori strains in Japan |
| Q34041903 | Distinct diversity of vacA, cagA, and cagE genes of Helicobacter pylori associated with peptic ulcer in Japan |
| Q40340015 | Distinct host species correlate with Anaplasma phagocytophilum ankA gene clusters |
| Q36118046 | Distinct repeat motifs at the C-terminal region of CagA of Helicobacter pylori strains isolated from diseased patients and asymptomatic individuals in West Bengal, India |
| Q37451841 | Diverse characteristics of the CagA gene of Helicobacter pylori strains collected from patients from southern vietnam with gastric cancer and peptic ulcer |
| Q48063794 | Diversity of the cagA gene of Helicobacter pylori strains from patients with gastroduodenal diseases in the Philippines |
| Q27308055 | Dramatic increase in SHP2 binding activity of Helicobacter pylori Western CagA by EPIYA-C duplication: its implications in gastric carcinogenesis |
| Q37712106 | Dynamic Expansion and Contraction of cagA Copy Number in Helicobacter pylori Impact Development of Gastric Disease. |
| Q40435105 | EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells |
| Q53316283 | Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX-2 expression in patients with chronic gastritis and gastric cancer. |
| Q33766565 | Effector prediction in host-pathogen interaction based on a Markov model of a ubiquitous EPIYA motif |
| Q44328654 | Effects of Helicobacter pylori on intracellular Ca2+ signaling in normal human gastric mucous epithelial cells |
| Q33627481 | Epidemiological link between gastric disease and polymorphisms in VacA and CagA. |
| Q52801849 | Epidemiology of Helicobacter pylori and CagA-Positive Infections and Global Variations in Gastric Cancer. |
| Q58107248 | Evaluating the origin and virulence of a Helicobacter pylori cagA-positive strain isolated from a non-human primate |
| Q36556625 | Evaluation of the Pattern of EPIYA Motifs in the Helicobacter pylori cagA Gene of Patients with Gastritis and Gastric Adenocarcinoma from the Brazilian Amazon Region |
| Q37410049 | Evaluation of the anti-East Asian CagA-specific antibody for CagA phenotyping |
| Q33901410 | Evolution in an oncogenic bacterial species with extreme genome plasticity: Helicobacter pylori East Asian genomes |
| Q28741492 | Evolution of cagA oncogene of Helicobacter pylori through recombination |
| Q24630210 | Evolutionary History of the Helicobacter pylori Genome: Implications for Gastric Carcinogenesis |
| Q33399907 | Expression of Helicobacter pylori CagA domains by library-based construct screening |
| Q40329734 | Expression of MicroRNA in Host Cells Infected with Helicobacter pylori |
| Q33626756 | Factors that mediate colonization of the human stomach by Helicobacter pylori |
| Q40725761 | Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. |
| Q35087443 | Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains |
| Q33892318 | Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells |
| Q39838743 | Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy. |
| Q37716152 | Gastric cancer: overview |
| Q40403347 | Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pyloricagA genotype |
| Q36483526 | Gastric-to-intestinal transdifferentiation and cancer |
| Q46156911 | Genetic signatures for Helicobacter pylori strains of West African origin |
| Q40239139 | Genetic variants of Helicobacter pylori type IV secretion system components CagL and CagI and their association with clinical outcomes |
| Q33397617 | Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer |
| Q54424362 | Genomic fluidity and pathogenic bacteria: applications in diagnostics, epidemiology and intervention. |
| Q34593167 | Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. |
| Q26774708 | Gut microbiota imbalance and colorectal cancer |
| Q38190020 | H. pylori infection, inflammation and gastric cancer |
| Q35861502 | H. pylori infection: bacterial virulence factors and cytokine gene polymorphisms as determinants of infection outcome |
| Q40028459 | HELICOBACTER PYLORI INFECTION IN PATIENTS WITH DIFFERENT GASTROINTESTINAL DISEASES FROM NORTHERN BRAZIL. |
| Q53334117 | Helicobacter and gastrin stimulate Reg1 expression in gastric epithelial cells through distinct promoter elements. |
| Q44568920 | Helicobacter pylori CagA as a potential bacterial oncoprotein in gastric carcinogenesis |
| Q30490728 | Helicobacter pylori CagA causes mitotic impairment and induces chromosomal instability |
| Q40668540 | Helicobacter pylori CagA containing ITAM-like sequences localized to lipid rafts negatively regulates VacA-induced signaling in vivo |
| Q38715427 | Helicobacter pylori CagA induced interleukin-8 secretion in gastric epithelial cells |
| Q30479101 | Helicobacter pylori CagA induces AGS cell elongation through a cell retraction defect that is independent of Cdc42, Rac1, and Arp2/3. |
| Q33292148 | Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation |
| Q90553231 | Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells |
| Q34073621 | Helicobacter pylori CagA protein polymorphisms and their lack of association with pathogenesis |
| Q42064313 | Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response |
| Q40131894 | Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. |
| Q39672903 | Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation |
| Q40338115 | Helicobacter pylori CagA transfection of gastric epithelial cells induces interleukin-8. |
| Q34152656 | Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation |
| Q35090018 | Helicobacter pylori CagA--a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins |
| Q28287897 | Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis |
| Q26774217 | Helicobacter pylori Diversity and Gastric Cancer Risk |
| Q26865062 | Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography |
| Q37545390 | Helicobacter pylori VacA, acting through receptor protein tyrosine phosphatase α, is crucial for CagA phosphorylation in human duodenum carcinoma cell line AZ-521 |
| Q39995116 | Helicobacter pylori and CagA under conditions of iron deficiency |
| Q24803698 | Helicobacter pylori and gastroduodenal pathology: new threats of the old friend |
| Q37812388 | Helicobacter pylori and its effect on innate and adaptive immunity: new insights and vaccination strategies |
| Q40286645 | Helicobacter pylori as an oncogenic pathogen, revisited. |
| Q41879549 | Helicobacter pylori cagA gene variants in Malaysians of different ethnicity. |
| Q53150251 | Helicobacter pylori cagA polymorphism and gastric inflammation: an international comparison between Japanese and Brazilian patients. |
| Q81608194 | Helicobacter pylori cagA status and peptic ulcer disease in Iran |
| Q33508239 | Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells |
| Q35783436 | Helicobacter pylori detection and antimicrobial susceptibility testing |
| Q36823720 | Helicobacter pylori evolution and phenotypic diversification in a changing host |
| Q33294056 | Helicobacter pylori evolution: lineage- specific adaptations in homologs of eukaryotic Sel1-like genes |
| Q37734437 | Helicobacter pylori genetic diversity and gastro-duodenal diseases in Malaysia |
| Q35192226 | Helicobacter pylori homB, but not cagA, is associated with gastric cancer in Iran |
| Q36816611 | Helicobacter pylori in health and disease |
| Q37204035 | Helicobacter pylori induces cancer cell motility independent of the c-Met receptor |
| Q26769946 | Helicobacter pylori infection and gastric carcinoma: Not all the strains and patients are alike |
| Q39767306 | Helicobacter pylori infection is associated with a high incidence of intestinal metaplasia in the gastric mucosa of patients at inner-city hospitals in New York |
| Q73042579 | Helicobacter pylori infection, mucosal atrophy and intestinal metaplasia in Asian populations: a comparative study in age-, gender- and endoscopic diagnosis-matched subjects |
| Q26750909 | Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis |
| Q34657491 | Helicobacter pylori seropositivities and risk of pancreatic carcinoma |
| Q40138092 | Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and -independent ERK activation |
| Q44601444 | Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa |
| Q37585441 | Helicobacter pylori typing as a tool for tracking human migration |
| Q38544635 | Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways |
| Q35916802 | Helicobacter pylori virulence factors affecting gastric proton pump expression and acid secretion |
| Q38582534 | Helicobacter pylori virulence factors in development of gastric carcinoma |
| Q37353613 | Helicobacter pylori virulence factors in gastric carcinogenesis |
| Q36125580 | Helicobacter pylori virulence genes in the five largest islands of Indonesia |
| Q42375188 | Helicobacter pylori virulence genes of minor ethnic groups in North Thailand |
| Q49199872 | Helicobacter pylori-Induced HB-EGF Upregulates Gastrin Expression via the EGF Receptor, C-Raf, Mek1, and Erk2 in the MAPK Pathway. |
| Q38297950 | Helicobacter pylori-associated gastritis is related to babA2 expression without heterogeneity of the 3' region of the cagA genotype in gastric biopsy specimens |
| Q37760037 | Helicobacter pylori: gastric cancer and beyond |
| Q37405614 | Helicobacter pylori: phenotypes, genotypes and virulence genes. |
| Q36745437 | Helicobacter pylori: present status and future prospects in Japan |
| Q48641425 | Helicobacter pylori CagA promotes Snail-mediated epithelial-mesenchymal transition by reducing GSK-3 activity. |
| Q37648701 | Hepatocellular carcinoma: prevalence and molecular pathogenesis of Helicobacter spp. |
| Q35913569 | Heterogeneity in the activity of Mexican Helicobacter pylori strains in gastric epithelial cells and its association with diversity in the cagA gene. |
| Q34334120 | Higher glucose level can enhance the H. pylori adhesion and virulence related with type IV secretion system in AGS cells |
| Q40559303 | Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus |
| Q33983306 | Host-interactive genes in Amerindian Helicobacter pylori diverge from their Old World homologs and mediate inflammatory responses |
| Q35940300 | Identification of a Latin American-specific BabA adhesin variant through whole genome sequencing of Helicobacter pylori patient isolates from Nicaragua |
| Q40604274 | Impact of structural polymorphism for the Helicobacter pylori CagA oncoprotein on binding to polarity-regulating kinase PAR1b. |
| Q35133419 | Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase. |
| Q36248205 | Inducible nitric oxide synthetase genotype and Helicobacter pylori infection affect gastric cancer risk |
| Q24676709 | Inflammation, atrophy, and gastric cancer |
| Q34708847 | Intact cag pathogenicity island of Helicobacter pylori without disease association in Kolkata, India |
| Q35806104 | J-Western forms of Helicobacter pylori cagA constitute a distinct phylogenetic group with a widespread geographic distribution |
| Q34037421 | Latest insights into the effects of Helicobacter pylori infection on gastric carcinogenesis |
| Q37333631 | Linking epithelial polarity and carcinogenesis by multitasking Helicobacter pylori virulence factor CagA. |
| Q85614091 | Long-term monitoring of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication |
| Q37036006 | Mechanism and Function of Type IV Secretion During Infection of the Human Host |
| Q35726552 | Molecular Epidemiology of Helicobacter pylori Infection in Nepal: Specific Ancestor Root |
| Q91718644 | Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis |
| Q39235977 | Molecular subtypes in cancers of the gastrointestinal tract |
| Q35858143 | Multistep activation of the Helicobacter pylori effector CagA |
| Q33878876 | NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein |
| Q35126206 | Natural history of Helicobacter pylori infection |
| Q43133276 | Natural variant of the Helicobacter pylori CagA oncoprotein that lost the ability to interact with PAR1. |
| Q37166923 | New and Unexpected Biological Functions for the Src-Homology 2 Domain-Containing Phosphatase SHP-2 in the Gastrointestinal Tract |
| Q37832453 | New insights into the inactivation of gastric tumor suppressor RUNX3: the role of H. pylori infection |
| Q38903196 | Novel effects of Helicobacter pylori CagA on key genes of gastric cancer signal transduction: a comparative transfection study |
| Q28280246 | Oncogenic mechanisms of the Helicobacter pylori CagA protein |
| Q55040764 | Opinion: Bacterial toxins and cancer--a case to answer? |
| Q36083773 | Orchestration of aberrant epithelial signaling by Helicobacter pylori CagA. |
| Q36659803 | Overview: Helicobacter pylori and extragastric disease |
| Q89379599 | Past Questions and Current Understanding About Gastric Cancer |
| Q33361550 | Pathobiology of Helicobacter pylori-Induced Gastric Cancer |
| Q24679810 | Pathogenesis of Helicobacter pylori infection |
| Q79293792 | Pathogenesis of Helicobacter pylori infection |
| Q46060790 | Pathogenetic role of the tyrosine-phosphorylated CagA EPIYA sequence of Helicobacter pylori in histological gastritis in Japanese patients |
| Q37213952 | Pediatric Helicobacter pylori isolates display distinct gene coding capacities and virulence gene marker profiles |
| Q37728541 | Phosphatase regulation of intercellular junctions |
| Q93048817 | Phylogenetic analysis of clinical strains of Helicobacter pylori isolated from patients with gastric diseases in Tibet |
| Q28743625 | Phylogenetic analysis, based on EPIYA repeats in the cagA gene of Indian Helicobacter pylori, and the implications of sequence variation in tyrosine phosphorylation motifs on determining the clinical outcome |
| Q37156868 | Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. |
| Q27005785 | Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease |
| Q34487669 | Polymorphisms in the intermediate region of VacA impact Helicobacter pylori-induced disease development |
| Q40548677 | Population Evolution of Helicobacter pylori through Diversification in DNA Methylation and Interstrain Sequence Homogenization. |
| Q39535480 | Positive selection on a bacterial oncoprotein associated with gastric cancer |
| Q35311984 | Potentiation of Helicobacter pylori CagA protein virulence through homodimerization |
| Q34586831 | Presence of terminal EPIYA phosphorylation motifs in Helicobacter pylori CagA contributes to IL-8 secretion, irrespective of the number of repeats. |
| Q45719569 | Prevalence, risk factors, and virulence genes of Helicobacter pylori among dyspeptic patients in two different gastric cancer risk regions of Thailand |
| Q34197057 | Prevention of Gastric Cancer: When is Treatment of Helicobacter Pylori Warranted? |
| Q36090021 | Prevention of gastric cancer by Helicobacter pylori eradication |
| Q38932036 | Quantitative Detection and Genotyping of Helicobacter pylori from Stool using Droplet Digital PCR Reveals Variation in Bacterial Loads that Correlates with cagA Virulence Gene Carriage |
| Q80167953 | Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan |
| Q36049119 | Repressed TGF-β signaling through CagA-Smad3 interaction as pathogenic mechanisms of Helicobacter pylori-associated gastritis |
| Q35202215 | Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide |
| Q34277447 | Risk assessment of gastric cancer caused by Helicobacter pylori using CagA sequence markers |
| Q33689012 | Role of Helicobacter pylori CagA molecular variations in induction of host phenotypes with carcinogenic potential |
| Q34418497 | Role of Helicobacter pylori cagA EPIYA motif and vacA genotypes for the development of gastrointestinal diseases in Southeast Asian countries: a meta-analysis |
| Q54232446 | Role of Helicobacter pylori infection and lifestyle habits in the development of gastroduodenal diseases in a population from the Brazilian Amazon. |
| Q38173352 | Role of Helicobacter pylori virulence factor cytotoxin-associated gene A in gastric mucosa-associated lymphoid tissue lymphoma |
| Q55318438 | Role of gut microbiota in the pathogenesis of colorectal cancer; a review article. |
| Q34343194 | Role of innate immunity in Helicobacter pylori-induced gastric malignancy |
| Q37371715 | Role of partitioning-defective 1/microtubule affinity-regulating kinases in the morphogenetic activity of Helicobacter pylori CagA. |
| Q37781064 | Role of virulence factors and host cell signaling in the recognition of Helicobacter pylori and the generation of immune responses. |
| Q33612053 | Sequence Polymorphism and Intrinsic Structural Disorder as Related to Pathobiological Performance of the Helicobacter pylori CagA Oncoprotein |
| Q45236839 | Sequence analysis of East Asian cagA of Helicobacter pylori isolated from asymptomatic healthy Japanese and Thai individuals |
| Q33243531 | Sequence specificity of SHP-1 and SHP-2 Src homology 2 domains. Critical roles of residues beyond the pY+3 position |
| Q37296566 | Seroprevalences ofHelicobacter pylori infection and chronic atrophic gastritis in the united Republic of Tanzania and the Dominican Republic |
| Q34605404 | Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. |
| Q91762222 | Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations |
| Q35142697 | Show me the substrates: modulation of host cell function by type IV secretion systems. |
| Q41358979 | Signature of positive selection of PTK6 gene in East Asian populations: a cross talk for Helicobacter pylori invasion and gastric cancer endemicity |
| Q41040149 | Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR |
| Q45949802 | Stability of Helicobacter pylori CagA oncoprotein in human gastric epithelial cells. |
| Q35690396 | Strategy to characterize the number and type of repeating EPIYA phosphorylation motifs in the carboxyl terminus of CagA protein in Helicobacter pylori clinical isolates |
| Q27671618 | Structural insights into Helicobacter pylori oncoprotein CagA interaction with 1 integrin |
| Q39245190 | Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer |
| Q41952134 | Surreptitious manipulation of the human host by Helicobacter pylori |
| Q39237328 | Survival of Helicobacter pylori in gastric acidic territory. |
| Q28902456 | Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1 |
| Q43581382 | Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication |
| Q27027804 | The Helicobacter pylori cag Pathogenicity Island |
| Q40202131 | The Helicobacter pylori virulence factor CagA promotes Erk1/2-mediated Bad phosphorylation in lymphocytes: a mechanism of CagA-inhibited lymphocyte apoptosis |
| Q40101886 | The Middle Fragment of Helicobacter pylori CagA Induces Actin Rearrangement and Triggers Its Own Uptake into Gastric Epithelial Cells. |
| Q33849962 | The Relationship between H. pylori Infection and Osteoporosis in Japan |
| Q92480086 | The analysis of virulence factors and antibiotic resistance between Helicobacter pylori strains isolated from gastric antrum and body |
| Q39907723 | The autophagic induction in Helicobacter pylori-infected macrophage |
| Q82910676 | The cag PAI is intact and functional but HP0521 varies significantly in Helicobacter pylori isolates from Malaysia and Singapore |
| Q75301767 | The diversity of vacA and cagA genes of Helicobacter pylori in East Asia |
| Q35553965 | The enigma of Helicobacter pylori infection and gastric cancer |
| Q58752500 | The impacts of H. pylori virulence factors on the development of gastroduodenal diseases |
| Q42575600 | The many roads traveled by Helicobacter pylori to NFκB activation |
| Q54323281 | The number of Helicobacter pylori CagA EPIYA C tyrosine phosphorylation motifs influences the pattern of gastritis and the development of gastric carcinoma. |
| Q36012984 | The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention |
| Q36659807 | The role of Helicobacter pylori CagA in gastric carcinogenesis |
| Q40430260 | Transformed immortalized gastric epithelial cells by virulence factor CagA of Helicobacter pylori through Erk mitogen-activated protein kinase pathway |
| Q36459009 | Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse |
| Q41040797 | Tyrosine phosphorylation of CagA from Chinese Helicobacter pylori isolates in AGS gastric epithelial cells |
| Q34058754 | Vacuolating cytotoxin genotypes are strong markers of gastric cancer and duodenal ulcer-associated Helicobacter pylori strains: a matched case-control study |
| Q35908122 | Validation of Urine Test for Detection of Helicobacter pylori Infection in Indonesian Population. |
| Q40233533 | Variations in the multimerization region of the Helicobacter pylori cytotoxin CagA affect virulence |
| Q48600558 | World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. |
| Q57939042 | associated factors in the development of gastric cancer with special reference to the early-onset subtype |
| Q35858125 | c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains |
| Q92553031 | cagA gene EPIYA motif genetic characterization from Colombian Helicobacter pylori isolates: Standardization of a molecular test for rapid clinical laboratory detection |
| Q39382674 | p27(kip1) upregulated by hnRNPC1/2 antagonizes CagA (a virulence factor of Helicobacter pylori)-mediated pathogenesis |
| Q49837669 | vacA s1m1 genotype and cagA EPIYA-ABC pattern are predominant among Helicobacter pylori strains isolated from Mexican patients with chronic gastritis. |
Search more.